Skip to content
    AQST stock page

    Aquestive Therapeutics, Inc.

    AQST · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 12, 2026

      Aquestive Q2 FY26 — Anaphylm Resubmission On Track, Strong Clinical Data

      Read the brief

    Browse all US companies on the earnings-call register.